TKR 1785
Latest Information Update: 15 Jun 2001
At a glance
- Originator Takara Shuzo
- Class Antifungals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 15 Jun 2001 No-Development-Reported for Mycoses in Japan (Unknown route)
- 27 Nov 1997 New profile
- 27 Nov 1997 Preclinical development for Mycoses in Japan (Unknown route)